173 related articles for article (PubMed ID: 17593169)
21. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
Caruntu FA; Gheorghita V
J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
[No Abstract] [Full Text] [Related]
22. Autoimmune hepatitis in a child with chronic hepatitis B virus infection.
Venkatasubramani N; Szabo S; Werlin SL
J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):639-41. PubMed ID: 19561549
[No Abstract] [Full Text] [Related]
23. [Up-to-date algorithms for diagnosis and treatment of chronic hepatitis B].
Maev IV; Polunina TE; Polunina EV
Klin Med (Mosk); 2009; 87(8):7-12. PubMed ID: 19827522
[TBL] [Abstract][Full Text] [Related]
24. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
25. [Influence of the treatment of chronic hepatitis B on HBV DNA suppression and prevention of disease progression].
Pawłowska M
Przegl Epidemiol; 2008; 62(1):139-42. PubMed ID: 18536236
[TBL] [Abstract][Full Text] [Related]
26. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of HIV-HBV-coinfection].
Mauss S
MMW Fortschr Med; 2009 Apr; 151(18):49-50, 52-3. PubMed ID: 19769076
[No Abstract] [Full Text] [Related]
28. Genotyping and genomic sequencing in clinical practice.
Gish RG; Locarnini S
Clin Liver Dis; 2007 Nov; 11(4):761-95, viii. PubMed ID: 17981228
[TBL] [Abstract][Full Text] [Related]
29. Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
Keeffe EB; Zeuzem S; Koff RS; Dieterich DT; Esteban-Mur R; Gane EJ; Jacobson IM; Lim SG; Naoumov N; Marcellin P; Piratvisuth T; Zoulim F
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):890-7. PubMed ID: 17632041
[TBL] [Abstract][Full Text] [Related]
30. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
[TBL] [Abstract][Full Text] [Related]
31. New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B.
Feld J; Lee JY; Locarnini S
Hepatology; 2003 Sep; 38(3):545-53. PubMed ID: 12939579
[No Abstract] [Full Text] [Related]
32. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
33. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
34. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Dai CY; Chuang WL; Huang JF; Yu ML
Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
[No Abstract] [Full Text] [Related]
35. Treatment of chronic hepatitis B.
Loomba R; Liang TJ
Antivir Ther; 2007; 12 Suppl 3():H33-41. PubMed ID: 18284181
[TBL] [Abstract][Full Text] [Related]
36. [Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy].
Wu YZ; Zhao FL; Zhang CZ; Li MH; Xie Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):120-2. PubMed ID: 17653310
[TBL] [Abstract][Full Text] [Related]
37. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
38. Diagnosis, diagnostic tests and monitoring of hepatitis B virus in monoinfected and HIV-coinfected patients.
Thio CL
Antivir Ther; 2007; 12 Suppl 3():H25-31. PubMed ID: 18284180
[TBL] [Abstract][Full Text] [Related]
39. Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.
Jardi R; Rodriguez-Frias F; Schaper M; Giggi E; Tabernero D; Homs M; Esteban R; Buti M
J Hepatol; 2008 Nov; 49(5):695-701. PubMed ID: 18490074
[TBL] [Abstract][Full Text] [Related]
40. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
Isakov VA
Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
